Published in J Virol on July 01, 1992
Mechanism of action of regulatory proteins encoded by complex retroviruses. Microbiol Rev (1992) 3.60
Complementation of vif-defective human immunodeficiency virus type 1 by primate, but not nonprimate, lentivirus vif genes. J Virol (1995) 2.35
Nonreciprocal packaging of human immunodeficiency virus type 1 and type 2 RNA: a possible role for the p2 domain of Gag in RNA encapsidation. J Virol (1998) 1.64
Identification of the activation domain of equine infectious anemia virus rev. J Virol (1993) 1.57
Persistence of attenuated rev genes in a human immunodeficiency virus type 1-infected asymptomatic individual. J Virol (1995) 1.48
The HIV-2 Rev-response element: determining secondary structure and defining folding intermediates. Nucleic Acids Res (2013) 0.80
Transcomplementation of simian immunodeficiency virus Rev with human T-cell leukemia virus type I Rex. J Virol (1993) 0.75
Specific synthesis of DNA in vitro via a polymerase-catalyzed chain reaction. Methods Enzymol (1987) 58.68
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase. Gene (1988) 52.71
Direct chemical method for sequencing RNA. Proc Natl Acad Sci U S A (1979) 25.15
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92
HTLV-III expression and production involve complex regulation at the levels of splicing and translation of viral RNA. Cell (1986) 12.74
Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol (1987) 12.66
A second post-transcriptional trans-activator gene required for HTLV-III replication. Nature (1986) 10.76
rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA. Proc Natl Acad Sci U S A (1989) 8.76
Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell (1989) 7.46
The rev gene product of the human immunodeficiency virus affects envelope-specific RNA localization. Cell (1989) 6.13
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell (1990) 5.82
Regulation of human immunodeficiency virus env expression by the rev gene product. J Virol (1989) 5.79
Sequence-specific RNA binding by the HIV-1 Rev protein. Nature (1989) 5.36
Specific binding of HIV-1 recombinant Rev protein to the Rev-responsive element in vitro. Nature (1989) 4.96
Steroid-receptor fusion of the human immunodeficiency virus type 1 Rev transactivator: mapping cryptic functions of the arginine-rich motif. Proc Natl Acad Sci U S A (1990) 4.63
HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell (1991) 4.61
HIV-1 Rev regulation involves recognition of non-Watson-Crick base pairs in viral RNA. Cell (1991) 4.43
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol (1991) 3.94
Structural analysis of the interaction between the human immunodeficiency virus Rev protein and the Rev response element. Proc Natl Acad Sci U S A (1991) 3.06
Interaction of the human immunodeficiency virus type 1 Rev protein with a structured region in env mRNA is dependent on multimer formation mediated through a basic stretch of amino acids. Genes Dev (1990) 2.87
Oligomerization and RNA binding domains of the type 1 human immunodeficiency virus Rev protein: a dual function for an arginine-rich binding motif. Proc Natl Acad Sci U S A (1991) 2.66
Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein. Nature (1990) 2.47
Specific interaction of the human immunodeficiency virus Rev protein with a structured region in the env mRNA. Proc Natl Acad Sci U S A (1990) 2.47
Human immunodeficiency virus type 1 regulator of virion expression, rev, forms nucleoprotein filaments after binding to a purine-rich "bubble" located within the rev-responsive region of viral mRNAs. Proc Natl Acad Sci U S A (1991) 2.19
Identification of trans-dominant HIV-1 rev protein mutants by direct transfer of bacterially produced proteins into human cells. Nucleic Acids Res (1990) 2.14
Specific regulation of mRNA splicing in vitro by a peptide from HIV-1 Rev. Cell (1991) 2.05
Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate. Nucleic Acids Res (1991) 1.96
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A (1992) 1.96
A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res (1990) 1.90
Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc Natl Acad Sci U S A (1989) 1.87
Functional similarity of HIV-I rev and HTLV-I rex proteins: identification of a new nucleolar-targeting signal in rev protein. Biochem Biophys Res Commun (1989) 1.73
Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA. Proc Natl Acad Sci U S A (1990) 1.49
Mutants in a conserved region near the carboxy-terminus of HIV-1 Rev identify functionally important residues and exhibit a dominant negative phenotype. Virology (1990) 1.48
Extensive sequence-specific information throughout the CAR/RRE, the target sequence of the human immunodeficiency virus type 1 Rev protein. J Virol (1992) 1.43
Functional mapping of the human immunodeficiency virus type 1 Rev RNA binding domain: new insights into the domain structure of Rev and Rex. J Virol (1991) 1.27
Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA. J Virol (1990) 1.24
Structural and functional analysis of the human immunodeficiency virus type 2 Rev protein. J Virol (1991) 0.91
Compatibility of rev gene activity in the four groups of primate lentiviruses. Virology (1991) 0.89
The HIV-1 rev trans-activator acts through a structured target sequence to activate nuclear export of unspliced viral mRNA. Nature (1989) 13.92
Use of eukaryotic expression technology in the functional analysis of cloned genes. Methods Enzymol (1987) 12.66
Trans-activation of human immunodeficiency virus occurs via a bimodal mechanism. Cell (1986) 10.71
Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science (1991) 10.53
Functional dissection of the HIV-1 Rev trans-activator--derivation of a trans-dominant repressor of Rev function. Cell (1989) 7.46
Immunodeficiency virus rev trans-activator modulates the expression of the viral regulatory genes. Nature (1988) 6.28
Secreted placental alkaline phosphatase: a powerful new quantitative indicator of gene expression in eukaryotic cells. Gene (1988) 6.13
HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence. Cell (1990) 5.82
Transcriptional interference in avian retroviruses--implications for the promoter insertion model of leukaemogenesis. Nature (1984) 5.26
Trans-activation of human immunodeficiency virus gene expression is mediated by nuclear events. Proc Natl Acad Sci U S A (1987) 4.91
HIV-1 structural gene expression requires the binding of multiple Rev monomers to the viral RRE: implications for HIV-1 latency. Cell (1991) 4.61
Productive human immunodeficiency virus type 1 (HIV-1) infection of nonproliferating human monocytes. J Exp Med (1991) 4.56
Novel interleukin-2 receptor subunit detected by cross-linking under high-affinity conditions. Science (1986) 4.30
Protein sequence requirements for function of the human T-cell leukemia virus type 1 Rex nuclear export signal delineated by a novel in vivo randomization-selection assay. Mol Cell Biol (1996) 4.10
Mutational definition of the human immunodeficiency virus type 1 Rev activation domain. J Virol (1991) 3.94
Mutational analysis of the trans-activation-responsive region of the human immunodeficiency virus type I long terminal repeat. J Virol (1988) 3.69
Identification of a novel cellular cofactor for the Rev/Rex class of retroviral regulatory proteins. Cell (1995) 3.55
Nef protein of human immunodeficiency virus type 1: evidence against its role as a transcriptional inhibitor. Proc Natl Acad Sci U S A (1989) 3.43
Functional replacement of the HIV-1 rev protein by the HTLV-1 rex protein. Nature (1988) 3.31
Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. J Exp Med (1993) 3.29
The human Tap protein is a nuclear mRNA export factor that contains novel RNA-binding and nucleocytoplasmic transport sequences. Genes Dev (1999) 3.24
Comparative analysis of the HTLV-I Rex and HIV-1 Rev trans-regulatory proteins and their RNA response elements. Genes Dev (1989) 3.09
Recruitment of a protein complex containing Tat and cyclin T1 to TAR governs the species specificity of HIV-1 Tat. EMBO J (1998) 3.05
A second human interleukin-2 binding protein that may be a component of high-affinity interleukin-2 receptors. Nature (1987) 3.00
The arginine-rich domains present in human immunodeficiency virus type 1 Tat and Rev function as direct importin beta-dependent nuclear localization signals. Mol Cell Biol (1999) 2.90
Mutational analysis of the conserved basic domain of human immunodeficiency virus tat protein. J Virol (1989) 2.89
HIV-1-induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR-5 co-receptor. EMBO J (1997) 2.86
Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes. Mol Cell Biol (1993) 2.79
Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells. J Virol (2000) 2.72
Rev activates expression of the human immunodeficiency virus type 1 vif and vpr gene products. J Virol (1991) 2.62
Nuclear import of hnRNP A1 is mediated by a novel cellular cofactor related to karyopherin-beta. J Cell Sci (1997) 2.60
Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Curr Biol (1999) 2.52
The VP16 transcription activation domain is functional when targeted to a promoter-proximal RNA sequence. Genes Dev (1992) 2.24
Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. Genes Dev (1990) 2.24
Genetic analysis of the cofactor requirement for human immunodeficiency virus type 1 Tat function. J Virol (1993) 2.16
Characterization of the transcriptional trans activator of human foamy retrovirus. J Virol (1991) 2.12
Functional analysis of the transcription control region located within the avian retroviral long terminal repeat. Mol Cell Biol (1985) 2.12
Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein. Proc Natl Acad Sci U S A (1992) 1.96
Stable expression of transdominant Rev protein in human T cells inhibits human immunodeficiency virus replication. J Exp Med (1992) 1.93
Efficient polyadenylation within the human immunodeficiency virus type 1 long terminal repeat requires flanking U3-specific sequences. J Virol (1991) 1.91
Endogenous avian retroviruses contain deficient promoter and leader sequences. Proc Natl Acad Sci U S A (1983) 1.90
A highly conserved RNA folding region coincident with the Rev response element of primate immunodeficiency viruses. Nucleic Acids Res (1990) 1.90
Amphibian transcription factor IIIA proteins contain a sequence element functionally equivalent to the nuclear export signal of human immunodeficiency virus type 1 Rev. Proc Natl Acad Sci U S A (1996) 1.87
Functional comparison of the Rev trans-activators encoded by different primate immunodeficiency virus species. Proc Natl Acad Sci U S A (1989) 1.87
Identification of a novel human zinc finger protein that specifically interacts with the activation domain of lentiviral Tat proteins. Virology (1995) 1.84
Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc Natl Acad Sci U S A (1999) 1.82
Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. Science (1992) 1.76
Molecular basis of latency in pathogenic human viruses. Science (1991) 1.74
Adenomatous polyposis coli protein contains two nuclear export signals and shuttles between the nucleus and cytoplasm. Proc Natl Acad Sci U S A (2000) 1.67
Transcriptional activity of avian retroviral long terminal repeats directly correlates with enhancer activity. J Virol (1985) 1.67
The ability of HIV type 1 to use CCR-3 as a coreceptor is controlled by envelope V1/V2 sequences acting in conjunction with a CCR-5 tropic V3 loop. Proc Natl Acad Sci U S A (1998) 1.65
Genetic evidence that the Tat proteins of human immunodeficiency virus types 1 and 2 can multimerize in the eukaryotic cell nucleus. J Virol (1993) 1.62
Phosphorylation of the rev gene product of human immunodeficiency virus type 1. J Virol (1988) 1.61
Identification of a U5-specific sequence required for efficient polyadenylation within the human immunodeficiency virus long terminal repeat. J Virol (1989) 1.61
An ancient family of human endogenous retroviruses encodes a functional homolog of the HIV-1 Rev protein. Proc Natl Acad Sci U S A (1999) 1.59
Mutational analysis of the transcription activation domain of RelA: identification of a highly synergistic minimal acidic activation module. Mol Cell Biol (1994) 1.58
Molecular basis for cell tropism of CXCR4-dependent human immunodeficiency virus type 1 isolates. J Virol (2001) 1.58
Identification of the activation domain of equine infectious anemia virus rev. J Virol (1993) 1.57
Visna virus encodes a post-transcriptional regulator of viral structural gene expression. Proc Natl Acad Sci U S A (1990) 1.55
A nuclear role for the Fragile X mental retardation protein. EMBO J (1996) 1.54
COOH-terminal requirements for the correct processing of a phosphatidylinositol-glycan anchored membrane protein. J Biol Chem (1988) 1.52
Nuclear export of late HIV-1 mRNAs occurs via a cellular protein export pathway. Proc Natl Acad Sci U S A (1996) 1.52
APC-mediated downregulation of beta-catenin activity involves nuclear sequestration and nuclear export. EMBO Rep (2000) 1.50
Role of the avian retrovirus mRNA leader in expression: evidence for novel translational control. Mol Cell Biol (1986) 1.47
Effect of intron size on splicing efficiency in retroviral transcripts. Nucleic Acids Res (1982) 1.46
Expression of active, membrane-bound human placental alkaline phosphatase by transfected simian cells. Proc Natl Acad Sci U S A (1987) 1.44
The complete nucleotide sequence of the Vibrio harveyi bacteriophage VHML. J Appl Microbiol (2002) 1.43
Two closely related human nuclear export factors utilize entirely distinct export pathways. Mol Cell (2001) 1.43
In vitro selection of DNA elements highly responsive to the human T-cell lymphotropic virus type I transcriptional activator, Tax. Mol Cell Biol (1994) 1.43
The Bel-1 protein of human foamy virus activates human immunodeficiency virus type 1 gene expression via a novel DNA target site. J Virol (1992) 1.42
Conserved functional organization of the human immunodeficiency virus type 1 and visna virus Rev proteins. J Virol (1991) 1.41
Determination of the functional domain organization of the importin alpha nuclear import factor. J Cell Biol (1998) 1.40
Functional analysis of the Tat trans activator of human immunodeficiency virus type 2. J Virol (1989) 1.40
Multiple residues contribute to the inability of murine CCR-5 to function as a coreceptor for macrophage-tropic human immunodeficiency virus type 1 isolates. J Virol (1998) 1.36
Identification and functional characterization of a novel nuclear localization signal present in the yeast Nab2 poly(A)+ RNA binding protein. Mol Cell Biol (1998) 1.35
The human tap nuclear RNA export factor contains a novel transportin-dependent nuclear localization signal that lacks nuclear export signal function. J Biol Chem (1999) 1.28
Functional organization of the Bel-1 trans activator of human foamy virus. J Virol (1993) 1.27
Regulation of the human c-myc gene: 5' noncoding sequences do not affect translation. Mol Cell Biol (1985) 1.26
Functional analysis of interactions between Tat and the trans-activation response element of human immunodeficiency virus type 1 in cells. J Virol (1993) 1.24
Definition of a consensus transportin-specific nucleocytoplasmic transport signal. J Biol Chem (1999) 1.22
The human foamy virus Bel-1 transcription factor is a sequence-specific DNA binding protein. J Virol (1996) 1.22
Effect of RNA secondary structure on polyadenylation site selection. Genes Dev (1991) 1.21
Using viral species specificity to define a critical protein/RNA interaction surface. Genes Dev (2001) 1.20
Functional characterization of a complex protein-DNA-binding domain located within the human immunodeficiency virus type 1 long terminal repeat leader region. J Virol (1989) 1.19
Derivation of a biologically contained replication system for human immunodeficiency virus type 1. Proc Natl Acad Sci U S A (1992) 1.18
Chemokine receptors and human immunodeficiency virus infection. Front Biosci (1998) 1.18
Sequence requirements for Rev multimerization in vivo. Virology (1994) 1.18
Human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus Nef use distinct but overlapping target sites for downregulation of cell surface CD4. J Virol (1997) 1.17
The simian immunodeficiency virus Nef protein promotes degradation of CD4 in human T cells. J Biol Chem (1994) 1.17
A single stem-loop structure within the HTLV-1 Rex response element is sufficient to mediate Rex activity in vivo. Virology (1994) 1.17
Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology (1997) 1.14
Utilization of a mammalian cell-based RNA binding assay to characterize the RNA binding properties of picornavirus 3C proteinases. RNA (1998) 1.13
The role of avian retroviral LTRs in the regulation of gene expression and viral replication. Adv Virus Res (1985) 1.13
Does the human immunodeficiency virus Tat trans-activator contain a discrete activation domain? Virology (1990) 1.12
Structural and functional analysis of the avian leukemia virus constitutive transport element. RNA (1999) 1.08
Highly divergent lentiviral Tat proteins activate viral gene expression by a common mechanism. Mol Cell Biol (1999) 1.07
Functional differences between human and bovine immunodeficiency virus Tat transcription factors. J Virol (2000) 1.07
Analysis of cellular factors that mediate nuclear export of RNAs bearing the Mason-Pfizer monkey virus constitutive transport element. J Virol (2000) 1.07